MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $257,000 | -14.6% | 13,848 | -33.3% | 0.02% | +12.5% |
Q1 2022 | $301,000 | +2910.0% | 20,748 | +5087.0% | 0.02% | – |
Q4 2021 | $10,000 | -47.4% | 400 | -64.6% | 0.00% | -100.0% |
Q3 2021 | $19,000 | +280.0% | 1,131 | +725.5% | 0.00% | – |
Q2 2021 | $5,000 | -73.7% | 137 | -79.2% | 0.00% | -100.0% |
Q1 2021 | $19,000 | – | 660 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |